BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3109978)

  • 1. Epidermal growth factor and its receptor.
    Gill GN; Bertics PJ; Santon JB
    Mol Cell Endocrinol; 1987 Jun; 51(3):169-86. PubMed ID: 3109978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation.
    Lund KA; Lazar CS; Chen WS; Walsh BJ; Welsh JB; Herbst JJ; Walton GM; Rosenfeld MG; Gill GN; Wiley HS
    J Biol Chem; 1990 Nov; 265(33):20517-23. PubMed ID: 2173710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory features of the epidermal growth factor receptor.
    Gill GN; Santon JB; Bertics PJ
    J Cell Physiol Suppl; 1987; Suppl 5():35-41. PubMed ID: 3316253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase.
    Morrison P; Takishima K; Rosner MR
    J Biol Chem; 1993 Jul; 268(21):15536-43. PubMed ID: 8393447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the epidermal growth factor receptor by phosphorylation.
    Bertics PJ; Weber W; Cochet C; Gill GN
    J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
    Kawase T; Orikasa M; Ogata S; Burns DM
    Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis.
    Honegger AM; Szapary D; Schmidt A; Lyall R; Van Obberghen E; Dull TJ; Ullrich A; Schlessinger J
    Mol Cell Biol; 1987 Dec; 7(12):4568-71. PubMed ID: 3501826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane.
    Hunter T; Ling N; Cooper JA
    Nature; 1984 Oct 4-10; 311(5985):480-3. PubMed ID: 6090944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation.
    Velu TJ; Vass WC; Lowy DR; Beguinot L
    Mol Cell Biol; 1989 Apr; 9(4):1772-8. PubMed ID: 2786142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.
    Stern DF; Kamps MP
    EMBO J; 1988 Apr; 7(4):995-1001. PubMed ID: 3261240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
    Connelly PA; Stern DF
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential.
    Riedel H; Schlessinger J; Ullrich A
    Science; 1987 Apr; 236(4798):197-200. PubMed ID: 3494307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity.
    Davis RJ
    J Biol Chem; 1988 Jul; 263(19):9462-9. PubMed ID: 3379075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C and limited substrates for tyrosine kinase are involved in epidermal growth factor (EGF)-dependent growth of a human squamous cell carcinoma cell variant.
    Hirai M; Shimizu N
    Cell Struct Funct; 1990 Aug; 15(4):191-200. PubMed ID: 1701695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric EGFR/neu receptor in studies of neu function.
    Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
    Cancer Treat Res; 1992; 61():213-28. PubMed ID: 1360234
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EGF receptor: structure, regulation and potential role in malignancy.
    Thompson DM; Gill GN
    Cancer Surv; 1985; 4(4):767-88. PubMed ID: 2824044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
    Hauguel-DeMouzon S; Csermely P; Zoppini G; Kahn CR
    J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation.
    King CS; Cooper JA
    J Biol Chem; 1986 Aug; 261(22):10073-8. PubMed ID: 3015918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor (EGF) promotes phosphorylation at threonine-654 of the EGF receptor: possible role of protein kinase C in homologous regulation of the EGF receptor.
    Whiteley B; Glaser L
    J Cell Biol; 1986 Oct; 103(4):1355-62. PubMed ID: 3021781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.